Recent advances of bispecific antibodies in solid tumors

Cancer immunotherapy is the most exciting advancement in cancer therapy. Similar to immune checkpoint blockade and chimeric antigen receptor T cell (CAR-T), bispecific antibody (BsAb) is attracting more and more attention as a novel strategy of antitumor immunotherapy. BsAb not only offers an effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Shengnan, Li, Anping, Liu, Qian, Yuan, Xun, Xu, Hanxiao, Jiao, Dechao, Pestell, Richard G., Han, Xinwei, Wu, Kongming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5607507/
https://www.ncbi.nlm.nih.gov/pubmed/28931402
http://dx.doi.org/10.1186/s13045-017-0522-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5607507/
https://www.ncbi.nlm.nih.gov/pubmed/28931402
http://dx.doi.org/10.1186/s13045-017-0522-z

Ejemplares similares